Palmaz-Schatz coronary stent implantation without intravascular ultrasound and without subsequent anticoagulation: Clinical outcome

Journal of Invasive Cardiology

Volumn 8, Issue 4, 1996, Pages 185-190

  Keighley, Craig S ^a   Urban, Phillip ^a   Killer, Isabelle ^a   Chatelain, Pascal ^a   Morandini, Emmanuel ^a   Verin, Vitali ^a   Rutishauser, Wilhelm ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Antiplatelet therapy; Aspirin; Stent; Subacute thrombosis; Ticlopidine

Indexed keywords

EID: 0344313383     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Serruys PW, de Jaegere P, Keimeneij F, et al. for the Benestent Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-195.
2. Fischman DL, Leon MB, Baim DS, et al. for the STRESS Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Eng J Med 1994;331:496-501.
3. Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion following coronary balloon angioplasty. Circulation 1988;78:1121-1127.
4. Roubin GS, Cannon AD, Agrawal SK, et al. Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty. Circulation 1992;85:916-927.
5. George BS, Voorhees WD, Roubin GS, et al. Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: Clinical and angiographic outcomes J Am Coll Cardiol 1993;22:135-143.
6. Nath FC, Muller DWM, Ellis SG, et al. Thrombosis of flexible coil coronary stent: Frequency, predictors and clinical outcome. J Am Coll Cardiol 1993;21:622-627.
7. Popma JJ, Satler LF, Pichard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation 1993;88:1569-1578.
8. Morice MC, Zemour G, Benveniste E, et al. Intracoronary stenting without coumadin: One month results of a French multicenter study. Cathet Cardiovasc Diagn 1995;35:1-7.
9. Goldberg SL, Colombo A, Almagor Y, et al. Has the introduction of intravascular ultrasound guidance led to different clinical results in the deployment of intracoronary stents (Abstr)? Circulation 1994;90:I-612.
10. Urban P, Chatelain P, Brzostek T, et al. Bailout coronary stenting with 6F guiding catheters for failed balloon angioplasty. Am Heart J 1995;129:1078-1083.
11. Haude M, Erbel R, Issa H, et al. Subacute thrombotic complications after intracoronary implantation of Palmaz-Schatz stents. Am Heart J 1993;126:15-22.
12. Herrmann HC, Buchbinder M, Clemen MW, et al. Emergent use of balloon-expandable coronary artery stenting for failed percutaneous transluminal coronary angioplasty. Circulation 1992;86:812-819.
13. Shaknovich A, Moses JW, Bailey S, et al. for the STRESS Investigators. Subacute stent thrombosis in the stent restenosis study (STRESS): Clinical impact and predictive factors (Abstr). Circulation 1994;90:I-650.
14. Holmes DR, Garratt KN, Schwartz RS, White C, for the Medtronic Wiktor Stent Investigators. Timing of stent occlusion/thrombosis after stent placement (Abstr). J Am Coll Cardiol 1994;23:70A.
15. Cohen DJ, Krumholz HM, Sukin C, et al. for the STRESS Investigators. Economic outcomes in the randomized stent restenosis study (STRESS): In-hospital and one-year follow-up costs (Abstr). Circulation 1994;90:I-620.
16. Blengino S, Nakamura S, Hall P, et al. A cost analysis of intravascular ultrasound guided coronary stenting without anticoagulation vs. the traditional method of stenting with anticoagulation (Abstr). J Am Coll Cardiol 1995;25:197A.
17. Schatz RA, Baim DS, Leon MB, et al. Clinical experience with the Palmaz-Schatz coronary stent: Initial results of a multicenter study. Circulation 1991;83:148-161.
18. Russo RJ, Schatz RA, Sklar MA, et al. Ultrasound guided coronary stent placement without prolonged systemic anticoagulation (Abstr). J Am Coll Cardiol 1995;25:50A.
19. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995;332:238-248.
20. Hass WK, Easton JD, Adams HP Jr, et al. for the Ticlopidine Aspirin Stroke Study Group. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-507.
21. McTavish D, Faulds D, Goa KL. Ticlopidine: An updated review of its pharmacology and therapeutic use in platelet dependent disorders. Drugs 1990;40:238-259.
22. Gregorini L, Marco J, Fajadet J, et al. Reduction of hemostasis activation with a new anticoagulation protocol during PTCA and stent implantation (Abstr). J Invas Cardiol 1995;7:14A.
23. Barragan PT, Silvestri MA, Sainsous JB, et al. Coronary stenting without coumadin (Abstr). J Am Coll Cardiol 1994;23:336A.
24. Morice MC, Amor M, Benveniste E, et al.. Coronary stenting without coumadin, phase II, III, IV, V. Predictors of major complications (Abstr). Circulation 1995;92 (suppl):I-795.
25. Schömig A, Schühlen H, Blasini R, et al. Anticoagulation versus antiplatelet therapy after intracoronary Palmaz-Schatz stent placement: A prospective randomized trial. Circulation 1995;92 (suppl): I-280.
26. Blengino S, Maiello L, Hall P, et al. Randomized trial of coronary stent implantation without anticoagulation: Aspirin vs. ticlopidine (Abstr). Circulation 1994;90:I-124.
27. Mehan VK, Salzmann C, Kaufmann U, Meier B. Coronary stenting without anticoagulation. Cathet Cardiovasc Diagn 1995;34:137-140.